Inhibition of carrageenin-induced rat paw oedema by catecholamines and amine-depleting drugs.
D000818:Animals; D002351:Carrageenan; D002395:Catecholamines / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005341:Fibrinolysin / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D007490:Iproniazid / Q000627:therapeutic use; D007545:Isoproterenol / Q000627:therapeutic use; D007610:Kallikreins / Q000378:metabolism; D007704:Kininogens / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000627:therapeutic use; D010958:Plasminogen / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000627:therapeutic use; D012701:Serotonin / Q000097:blood; D014439:Tyramine / Q000627:therapeutic use
D002395:Catecholamines; D007704:Kininogens; D012701:Serotonin; D012110:Reserpine; D002351:Carrageenan; D010958:Plasminogen; D007490:Iproniazid; D007610:Kallikreins; D005341:Fibrinolysin; D007545:Isoproterenol; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D006145:Guanethidine